Static outliers for Fairfield Pms

There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain. At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical method code is openly available on GitHub here.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at ebmdatalab@phc.ox.ac.uk. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

Prescribing where Fairfield Pms is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Tazarotene 5 Preparations for psoriasis 87 0.06 0.0 0.0 70.71
Ethinylestradiol 1 Oestrogens and Hormone Replacement Therapy 159 0.01 0.0 0.0 37.30
Dexamethasone sodium phosphate 3 Use of corticosteroids 336 0.01 0.0 0.0 18.72
Phenoxybenzamine hydrochloride 3 Alpha-adrenoceptor blocking drugs 352 0.01 0.0 0.0 9.00
Low protein grains/flours 3 Foods for special diets 74 0.04 0.0 0.0 8.68

Prescribing where Fairfield Pms is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Terbinafine hydrochloride 17 Other antifungals 19 0.89 0.99 0.03 -2.86
Calcipotriol 59 Preparations for psoriasis 87 0.68 0.87 0.08 -2.34
Colecalciferol 1614 Vitamin D 1765 0.91 0.96 0.02 -1.97
Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 61
Colecalciferol 800unit tablets : 68
Accrete D3 tablets : 169
Adcal-D3 Lemon chewable tablets : 300
Adcal-D3 750mg/200unit caplets : 114
Calceos 500mg/400unit chewable tablets : 51
Calcichew D3 Forte chewable tablets : 55
Fultium-D3 800unit capsules : 48
Fultium-D3 20,000unit capsules : 39
Desunin 800unit tablets : 156
Evacal D3 1500mg/400unit chewable tablets : 488
Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 2
Colecalciferol 50,000unit tablets : 2
Fultium-D3 3,200unit capsules : 2
Plenachol D3 20,000unit capsules : 2
Colecalciferol 1,000unit capsules : 1
Colecalciferol 400unit capsules : 1
Colecalciferol 20,000unit tablets : 1
Colecalciferol 2,400units/ml oral drops sugar free : 1
Colecalciferol 50,000unit capsules : 1
Desunin 4,000unit tablets : 1
InVita D3 25,000units/1ml oral solution : 1
Thorens 10,000units/ml oral drops : 4
Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 3
InVita D3 50,000units/1ml oral solution : 3
Colecalciferol 1,000unit tablets : 20
Adcal-D3 chewable tablets tutti frutti : 10
InVita D3 50,000unit capsules : 10
Ciprofloxacin 4 Quinolones 7 0.57 0.86 0.15 -1.93
Moxonidine 0 Centrally-acting antihypertensive drugs 12 0.00 0.64 0.34 -1.92